Novo Nordisk to open AI hub in London
Pharmaceutical company Novo Nordisk sees great potential in artificial intelligence, AI, as a stepping stone for the development of new drugs - such great potential that the Danish pharmaceutical flagship is establishing a dedicated center for the purpose in London.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Xellia Pharmaceuticals and Civica extend collaboration
For subscribers